← Leaderboards
Amit Maity
University Of Pennsylvania
$4,832,230
Attributed
$6,951,688
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.1M · FY2005–23$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$18,417,612 · 7
By mechanism
P01$11,465,924 · 1
R01$6,294,451 · 3
P30$406,361 · 2
R41$250,876 · 1
Top collaborators
- Constantinos Koumenis5 shared
- Alexander Lin5 shared
- Andy J Minn5 shared
- Robert H Vonderheide5 shared
- E. John Wherry5 shared
- Louis I Schure1 shared
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Constantinos Koumenis$17,144,115
- Robert H Vonderheide$28,425,019
- Stephen Raymond Thom$6,841,868
- Alain H Rook$9,745,732
- Xiaowei Xu$9,845,570
Others in their field
Top investigators on “Radiation”
- Philip J Disaia · University Of California Irvine$135,204,929
- Walter John Curran · Thomas Jefferson University$132,574,833
- Richard L Schilsky · University Of Chicago$122,521,723
- Polly Chang · Sri International$120,948,376
- Maury Tigner · Cornell University$104,613,212
- Norman Wolmark · Nsabp Foundation, Inc.$104,551,329
Research focus
RadiationRadiation TherapyHypoxiaClinical TrialsMalignant NeoplasmsTumorPathway InteractionsSignal TransductionResponseRadiation ToleranceLeadClinicTumor OxygenationProgramsResearch PersonnelHead And Neck Squamous Cell CarcinomaPharmaceutical PreparationsRadiation ResponseProteinsInhibitor/AntagonistRadiosensitizationIn VivoMediatingPhosphorylation
Grant awards (30)
Radiobiology and Imaging Program$83,257
P30 · FY2023 · CA · contact PI
Radiation and checkpoint blockade for cancer immune therapy$2,263,439
P01 · FY2022 · CA
Combination of CB101 and radiation therapy in head and neck squamous cell carcinoma$250,876
R41 · FY2022 · CA
Radiobiology and Imaging Program$84,880
P30 · FY2022 · CA · contact PI
Radiation and checkpoint blockade for cancer immune therapy$2,275,599
P01 · FY2021 · CA
Radiobiology and Imaging Program$83,107
P30 · FY2021 · CA · contact PI
Radiobiology and Imaging Research Program$77,523
P30 · FY2020 · CA · contact PI
Radiation and checkpoint blockade for cancer immune therapy$2,286,184
P01 · FY2019 · CA
Improving radiation response by targeting O2 metabolism via the PI3K/mTOR pathway$354,058
R01 · FY2019 · CA · contact PI
Radiobiology and Imaging Research Program$77,594
P30 · FY2019 · CA · contact PI
Radiation and checkpoint blockade for cancer immune therapy$2,311,469
P01 · FY2018 · CA
Improving radiation response by targeting O2 metabolism via the PI3K/mTOR pathway$365,009
R01 · FY2018 · CA · contact PI
Using 18F-EF5 PET to measure hypoxia modulation by Nelfinavir in larynx cancer$351,104
R01 · FY2018 · CA · contact PI
Radiation and checkpoint blockade for cancer immune therapy$2,329,233
P01 · FY2017 · CA
Using 18F-EF5 PET to measure hypoxia modulation by Nelfinavir in larynx cancer$393,811
R01 · FY2017 · CA · contact PI
Improving radiation response by targeting O2 metabolism via the PI3K/mTOR pathway$365,009
R01 · FY2017 · CA · contact PI
Using 18F-EF5 PET to measure hypoxia modulation by Nelfinavir in larynx cancer$488,805
R01 · FY2016 · CA · contact PI
Improving radiation response by targeting O2 metabolism via the PI3K/mTOR pathway$365,009
R01 · FY2016 · CA · contact PI
Using 18F-EF5 PET to measure hypoxia modulation by Nelfinavir in larynx cancer$488,805
R01 · FY2015 · CA · contact PI
Improving radiation response by targeting O2 metabolism via the PI3K/mTOR pathway$365,009
R01 · FY2015 · CA · contact PI
Using 18F-EF5 PET to measure hypoxia modulation by Nelfinavir in larynx cancer$451,422
R01 · FY2014 · CA · contact PI
Regulation of VEGF/HIF-1 by AKT: Implications for Radiotherapy$249,165
R01 · FY2010 · CA · contact PI
Regulation of VEGF/HIF-1 by AKT: Implications for Radiotherapy$249,165
R01 · FY2009 · CA · contact PI
Regulation of VEGF/HIF-1 by AKT: Implications for Radiotherapy$249,165
R01 · FY2008 · CA · contact PI
Regulation of VEGF/HIF-1 by AKT: Implications for Radiotherapy$249,099
R01 · FY2007 · CA · contact PI
Regulation of VEGF/HIF-1 by AKT: Implications for Radiotherapy$255,792
R01 · FY2006 · CA · contact PI
Regulation of VEGF in Tumors by Ras, EGF and PTEN$263,506
R01 · FY2005 · CA
Regulation of VEGF in Tumors by Ras, EGF and PTEN$263,506
R01 · FY2004 · CA
Regulation of VEGF in Tumors by Ras, EGF and PTEN$263,506
R01 · FY2003 · CA
Regulation of VEGF in Tumors by Ras, EGF and PTEN$263,506
R01 · FY2002 · CA